YU47548B - 1,2-bis(aminometil)ciklobutan-platinski kompleksi i postupak za njihovu proizvodnju - Google Patents

1,2-bis(aminometil)ciklobutan-platinski kompleksi i postupak za njihovu proizvodnju

Info

Publication number
YU47548B
YU47548B YU1689A YU1689A YU47548B YU 47548 B YU47548 B YU 47548B YU 1689 A YU1689 A YU 1689A YU 1689 A YU1689 A YU 1689A YU 47548 B YU47548 B YU 47548B
Authority
YU
Yugoslavia
Prior art keywords
phenyl
alkyl
aminomethyl
bis
cyclobutane
Prior art date
Application number
YU1689A
Other languages
English (en)
Serbo-Croatian (sh)
Other versions
YU1689A (en
Inventor
W. Schumacher
J. Respondek
J. Engel
J. Pohl
R. Voehell
P. Hilgard
Original Assignee
Asta Medica Ag.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Ag. filed Critical Asta Medica Ag.
Priority to SI8910016A priority Critical patent/SI8910016A/sl
Publication of YU1689A publication Critical patent/YU1689A/xx
Priority to HRP-16/89A priority patent/HRP920573B1/xx
Publication of YU47548B publication Critical patent/YU47548B/sh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0086Platinum compounds
    • C07F15/0093Platinum compounds without a metal-carbon linkage
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Luminescent Compositions (AREA)
YU1689A 1988-01-09 1989-01-06 1,2-bis(aminometil)ciklobutan-platinski kompleksi i postupak za njihovu proizvodnju YU47548B (sh)

Priority Applications (2)

Application Number Priority Date Filing Date Title
SI8910016A SI8910016A (sl) 1988-01-09 1989-01-06 Postopek za proizvodnjo 1,2-bis (aminometil) ciklobutan-platina kompleksov
HRP-16/89A HRP920573B1 (en) 1988-01-09 1992-09-29 Process for the preparation of 1,2 bis(aminomethyl)cyclobutane-platinum complexes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3800415 1988-01-09

Publications (2)

Publication Number Publication Date
YU1689A YU1689A (en) 1990-12-31
YU47548B true YU47548B (sh) 1995-10-03

Family

ID=6344991

Family Applications (2)

Application Number Title Priority Date Filing Date
YU1689A YU47548B (sh) 1988-01-09 1989-01-06 1,2-bis(aminometil)ciklobutan-platinski kompleksi i postupak za njihovu proizvodnju
YU73894A YU49211B (sh) 1988-01-09 1994-12-15 Postupak za proizvodnju leka koji sadrži 1,2-bis-(aminometil)-ciklobutan-platinske komplekse

Family Applications After (1)

Application Number Title Priority Date Filing Date
YU73894A YU49211B (sh) 1988-01-09 1994-12-15 Postupak za proizvodnju leka koji sadrži 1,2-bis-(aminometil)-ciklobutan-platinske komplekse

Country Status (22)

Country Link
US (1) US5023335A (enExample)
EP (1) EP0324154B1 (enExample)
JP (1) JP2710654B2 (enExample)
AT (1) ATE86967T1 (enExample)
AU (1) AU611749B2 (enExample)
CA (1) CA1316177C (enExample)
DE (3) DE8817132U1 (enExample)
DK (1) DK174981B1 (enExample)
EG (1) EG19357A (enExample)
ES (1) ES2054778T3 (enExample)
FI (1) FI90875C (enExample)
GR (1) GR3007408T3 (enExample)
HK (1) HK67694A (enExample)
HU (1) HU203361B (enExample)
IE (1) IE63527B1 (enExample)
IL (1) IL88898A (enExample)
MC (1) MC2001A1 (enExample)
NO (1) NO173390C (enExample)
NZ (1) NZ227549A (enExample)
PT (1) PT89408B (enExample)
YU (2) YU47548B (enExample)
ZA (1) ZA89136B (enExample)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2056721B1 (es) * 1991-06-05 1995-05-01 Ferrer Int Mejoras en el objeto de la patente de invencion n{ 9101355 que se refiere a procedimiento de obtencion de nuevos derivados de platino con aminopirrolidinas.
ES2042364B1 (es) * 1991-06-05 1994-07-16 Ferrer Int Procedimiento de obtencion de nuevos derivados de platino con aminopirrolidinas.
DE4415263C1 (de) * 1994-04-15 1995-11-30 Asta Medica Ag Cis-[trans-1,2-Cyclobutanbis(methylamin)-N,N']-[(2S)-lactato-O·1·, O·2·]-platin(II)-trihydrat (Lobaplatin-Trihydrat), seine Herstellung und arzneiliche Verwendung
EP1013277A4 (en) * 1997-01-14 2002-04-17 Toray Industries LYOPHILIZED PREPARATIONS AND PROCESS FOR PRODUCING THE SAME
FR2772616B1 (fr) * 1997-12-24 2000-02-25 Caster Composition depigmentante
WO2010087976A2 (en) * 2009-01-31 2010-08-05 Igf Oncology, Llc Anti-cancer protein-platinum conjugates
CN102093226B (zh) * 2010-11-24 2013-12-04 贵州益佰制药股份有限公司 二氨甲基环丁烷草酸盐的制备方法
CN102020679B (zh) * 2010-11-24 2013-12-25 贵州益佰制药股份有限公司 一种以草酸盐制备洛铂三水合物的方法
WO2013083058A1 (zh) * 2011-12-07 2013-06-13 北京市丰硕维康技术开发有限责任公司 一类离去基团是含氨基或烷氨基的羟基酸衍生物的铂类化合物及其制备方法和应用
CN103467528B (zh) * 2013-08-21 2016-06-08 江苏奥赛康药业股份有限公司 一种洛铂的制备方法
RU2708311C2 (ru) 2014-04-25 2019-12-05 Блубёрд Био, Инк. Химерные антигенные рецепторы с mnd-промотором
ES2800906T3 (es) 2014-04-25 2021-01-05 Bluebird Bio Inc Métodos mejorados para producir terapias celulares adoptivas
RU2719030C2 (ru) 2014-06-06 2020-04-16 Блубёрд Био, Инк. Улучшенные композиции на основе t-клеток
JP6404461B2 (ja) * 2014-06-20 2018-10-10 貴州益佰制葯股▲ふん▼有限公司 ロバプラチン結晶体、調製方法及び薬物応用
CN105440083B (zh) * 2014-06-20 2018-08-14 贵州益佰制药股份有限公司 一种洛铂晶体、制备方法及药物应用
CN105198932B (zh) * 2014-06-20 2018-09-21 贵州益佰制药股份有限公司 洛铂二水合物、制备方法及药物应用
CN105440082B (zh) * 2014-06-20 2018-08-14 贵州益佰制药股份有限公司 一种洛铂晶体、制备方法及药物应用
CN105198933B (zh) * 2014-06-20 2018-08-14 贵州益佰制药股份有限公司 一种洛铂晶体、制备方法及药物应用
CN105330702B (zh) * 2014-06-20 2018-08-14 贵州益佰制药股份有限公司 一种洛铂晶体、制备方法及药物应用
CN105218587B (zh) * 2014-06-20 2018-08-14 贵州益佰制药股份有限公司 一种洛铂晶体、制备方法及药物应用
RU2747457C2 (ru) 2014-07-24 2021-05-05 Блубёрд Био, Инк. Химерные антигенные рецепторы к bcma
EA036379B1 (ru) 2014-12-12 2020-11-02 Блубёрд Био, Инк. Химерные антигенные рецепторы к bcma
WO2017099712A1 (en) 2015-12-07 2017-06-15 Bluebird Bio, Inc. Improved t cell compositions
CA3042424A1 (en) 2016-11-04 2018-05-11 Bluebird Bio, Inc. Anti-bcma car t cell compositions
CN108047277A (zh) * 2018-01-04 2018-05-18 昆明贵研药业有限公司 具有抗肿瘤活性的脂溶性铂配合物的制备方法
CN111718375A (zh) * 2019-03-19 2020-09-29 海南长安国际制药有限公司 具有g1和g2结构的铂类物质及其制备方法和应用
CN111718378B (zh) * 2019-03-19 2024-01-30 海南长安国际制药有限公司 具有式(k)结构的铂类化合物、制备及其检测方法
CN111721842B (zh) * 2019-03-19 2022-07-12 海南长安国际制药有限公司 洛铂中有关物质的检测方法
CN111718373A (zh) * 2019-03-19 2020-09-29 海南长安国际制药有限公司 具有式(i)结构的铂类化合物、制备及其应用
CN111721840B (zh) * 2019-03-19 2022-07-12 海南长安国际制药有限公司 洛铂中有关物质的检测
CN111718377A (zh) * 2019-03-19 2020-09-29 海南长安国际制药有限公司 具有结构式h1、h2的铂类物质、制备及其应用
CN113173953B (zh) * 2021-04-12 2022-06-10 昆明贵研药业有限公司 用于制备抗肿瘤药物的高纯洛铂三水合物的提纯方法
WO2024092045A1 (en) * 2022-10-25 2024-05-02 University Of Massachusetts Platinum(ii)-based anticancer agents, targeted conjugates, and method of synthesizing thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1618050A1 (de) * 1966-04-08 1970-01-02 Asahi Chemical Ind Verfahren zum Herstellen von 1,2-Diaminocyclobutan
GB1432562A (en) * 1972-04-10 1976-04-22 Rustenburg Platinum Mines Ltd Platinum co-ordination compounds
NL7807334A (nl) * 1978-07-06 1980-01-08 Tno Platina-diaminecomplexen, werkwijze voor het bereiden daarvan, werkwijze voor het bereiden van een genees- middel met toepassing van een dergelijk platina-dia- minecomplex voor de behandeling van kanker, alsmede al- dus verkregen gevormd geneesmiddel.
NL181434C (nl) * 1980-01-03 1987-08-17 Tno Platina(iv)-diamine-complexen, alsmede hun bereiding en toepassing.
US4322362A (en) * 1980-07-28 1982-03-30 Bristol-Myers Company Salts of 2-hydroxymalonate platinum complexes
JPS5716895A (en) * 1980-07-05 1982-01-28 Otsuka Chem Co Ltd Platinum 2 complex and antitumor agent containing the same as active principle
JPS617283A (ja) * 1984-06-20 1986-01-13 Shionogi & Co Ltd 新規白金錯体および抗悪性腫瘍剤
IL76889A0 (en) * 1984-11-02 1986-02-28 Johnson Matthey Plc Solubilised platinum compound,method for the production thereof and pharmaceutical compositions containing the same
ATE49214T1 (de) * 1984-12-17 1990-01-15 American Cyanamid Co Platinkomplexe von aliphatischen tricarbonsaeuren.
JPS62207283A (ja) * 1986-03-07 1987-09-11 Yoshinori Kitani 新規な白金錯体
EP0290169A3 (en) * 1987-05-04 1990-08-01 Engelhard Corporation Diamineplatinum complexes with phosphonocarboxylate and substituted phosphonocarboxylate ligands as antitumor agents

Also Published As

Publication number Publication date
DE3843571A1 (de) 1989-07-20
DE3879453D1 (en) 1993-04-22
DK5689A (da) 1989-07-10
ES2054778T3 (es) 1994-08-16
HU203361B (en) 1991-07-29
DK174981B1 (da) 2004-04-05
IE63527B1 (en) 1995-05-03
US5023335A (en) 1991-06-11
YU73894A (sh) 1997-09-30
EP0324154A3 (en) 1990-03-14
ATE86967T1 (de) 1993-04-15
PT89408B (pt) 1993-09-30
FI890068A7 (fi) 1989-07-10
DK5689D0 (da) 1989-01-06
EP0324154B1 (de) 1993-03-17
IL88898A0 (en) 1989-08-15
YU1689A (en) 1990-12-31
JP2710654B2 (ja) 1998-02-10
IE890041L (en) 1989-07-09
NZ227549A (en) 1990-05-28
NO890059L (no) 1989-07-10
YU49211B (sh) 2004-09-03
HK67694A (en) 1994-07-22
NO173390B (no) 1993-08-30
AU2779689A (en) 1989-07-20
AU611749B2 (en) 1991-06-20
GR3007408T3 (enExample) 1993-07-30
PT89408A (pt) 1990-02-08
HUT49363A (en) 1989-09-28
FI890068A0 (fi) 1989-01-06
EG19357A (en) 1994-12-30
IL88898A (en) 1993-07-08
DE8817132U1 (de) 1993-04-22
ZA89136B (en) 1989-10-25
MC2001A1 (fr) 1990-01-26
JPH02795A (ja) 1990-01-05
FI90875B (fi) 1993-12-31
EP0324154A2 (de) 1989-07-19
NO890059D0 (no) 1989-01-06
NO173390C (no) 1993-12-08
CA1316177C (en) 1993-04-13
FI90875C (fi) 1994-04-11

Similar Documents

Publication Publication Date Title
YU47548B (sh) 1,2-bis(aminometil)ciklobutan-platinski kompleksi i postupak za njihovu proizvodnju
NL171885C (nl) Werkwijze voor het verhinderen of belemmeren van het ontstaan van neerslagen en van afzettingen op wanden door hardheidsvormers en/of door gesuspendeerde vaste deeltjes in water, dat langs wanden stroomt.
DK0430863T4 (da) Kaskadepolymer-komplekser, anvendelse deraf og farmaceutiske midler der indeholder dem
BG101113A (bg) Триазолови съединения и тяхното използване
ATE222744T1 (de) Formulierungen und verfahren zur reduzierung von hautreizung
DK0724581T3 (da) Krystallinsk vandfri mycophenolatmofetil og intravenøs formulering deraf
ES419619A1 (es) Procedimiento para remineralizar una sub-superficie desmi- neralizada de un diente.
DE3751967D1 (de) Bisplatinum-komplexe als chemotherapeutisches mittel
ES2163723T3 (es) Nuevos compuestos moduladores de los receptores hormonales, las composiciones que los incluyen y su utilizacion en terapia.
PT93485A (pt) Processo de preparacao de derivados de 1h,3h-pirrolo{1,2-c}tiazol-7-carboxamida e de composicoes farmaceuticas que os contem
GB1504651A (en) Phosphonates
ATE106896T1 (de) Neue synthetische bioaktive verbindungen und verfahren zur herstellung bioaktiver wirkungen.
DE69131850D1 (de) Technetium-99m-komplexe zur verwendung als radiopharmazeutische mittel
WO1992020650A3 (en) Phosphite-borane compounds, and method of making and using the same
ATE179168T1 (de) Substituierte spiroverbindungen zur behandlung von entzündungen
FR2455039A1 (fr) Pyrimido et imidazo-pyrido-indole-diones et leur application en therapeutique
ES2020953B3 (es) Complejos de tetrahidro-3,4-furanodiamina-n-n'platino.
ES374929A1 (es) Procedimiento para la preparacion de l-3-(3,4-dihidroxife- nil)-alamina.
DE68913641D1 (de) Regenerierung von chelierten polyvalenten Metall-Lösungen durch kontrollierte Potential-Elektrolyse.
DE69432139D1 (de) Phosphin-Verbindungen, diese Phosphin-Verbindungen als ligande enthaltende Komplexe, Verfahren zur Herstellung von optisch-aktiven Aldehyden durch Mittel der Phosphin-Verbindungen oder des Komplexes
DE3578135D1 (de) Behandlung eines ultrafiltrats durch elektrodialyse.
BG48694A3 (en) Method for preparing alkandiol- dicarboxilates
CA2046313A1 (en) Platinum (ii) complex and agent for treating malignant tumor
DK519783D0 (da) Fremgangsmade til fremstilling af 1-aroyl-5-oxo-2-pyrrolidinpropansyrer samt beslaegtede estre samt kompositioner indeholdende disse
ATE32508T1 (de) Isomerisierung von 1,3,3-trimethyl-7oxabicyclo(4.1.0>heptan-2-on.